#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers


Genome-wide association studies (GWAS) have recently identified KIF1B as susceptibility locus for hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC). To further identify novel susceptibility loci associated with HBV–related HCC and replicate the previously reported association, we performed a large three-stage GWAS in the Han Chinese population. 523,663 autosomal SNPs in 1,538 HBV–positive HCC patients and 1,465 chronic HBV carriers were genotyped for the discovery stage. Top candidate SNPs were genotyped in the initial validation samples of 2,112 HBV–positive HCC cases and 2,208 HBV carriers and then in the second validation samples of 1,021 cases and 1,491 HBV carriers. We discovered two novel associations at rs9272105 (HLA-DQA1/DRB1) on 6p21.32 (OR = 1.30, P = 1.13×10−19) and rs455804 (GRIK1) on 21q21.3 (OR = 0.84, P = 1.86×10−8), which were further replicated in the fourth independent sample of 1,298 cases and 1,026 controls (rs9272105: OR = 1.25, P = 1.71×10−4; rs455804: OR = 0.84, P = 6.92×10−3). We also revealed the associations of HLA-DRB1*0405 and 0901*0602, which could partially account for the association at rs9272105. The association at rs455804 implicates GRIK1 as a novel susceptibility gene for HBV–related HCC, suggesting the involvement of glutamate signaling in the development of HBV–related HCC.


Vyšlo v časopise: GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers. PLoS Genet 8(7): e32767. doi:10.1371/journal.pgen.1002791
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002791

Souhrn

Genome-wide association studies (GWAS) have recently identified KIF1B as susceptibility locus for hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC). To further identify novel susceptibility loci associated with HBV–related HCC and replicate the previously reported association, we performed a large three-stage GWAS in the Han Chinese population. 523,663 autosomal SNPs in 1,538 HBV–positive HCC patients and 1,465 chronic HBV carriers were genotyped for the discovery stage. Top candidate SNPs were genotyped in the initial validation samples of 2,112 HBV–positive HCC cases and 2,208 HBV carriers and then in the second validation samples of 1,021 cases and 1,491 HBV carriers. We discovered two novel associations at rs9272105 (HLA-DQA1/DRB1) on 6p21.32 (OR = 1.30, P = 1.13×10−19) and rs455804 (GRIK1) on 21q21.3 (OR = 0.84, P = 1.86×10−8), which were further replicated in the fourth independent sample of 1,298 cases and 1,026 controls (rs9272105: OR = 1.25, P = 1.71×10−4; rs455804: OR = 0.84, P = 6.92×10−3). We also revealed the associations of HLA-DRB1*0405 and 0901*0602, which could partially account for the association at rs9272105. The association at rs455804 implicates GRIK1 as a novel susceptibility gene for HBV–related HCC, suggesting the involvement of glutamate signaling in the development of HBV–related HCC.


Zdroje

1. SenerSF 2005 Disease without borders. CA Cancer J Clin 55 7 9

2. JemalABrayFCenterMMFerlayJWardE 2011 Global cancer statistics. CA Cancer J Clin 61 69 90

3. YuMWHsuFCSheenISChuCMLinDY 1997 Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 145 1039 1047

4. YuMWChangHCLiawYFLinSMLeeSD 2000 Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92 1159 1164

5. KaoJHChenPJChenDS 2010 Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res 108 21 72

6. ZhangHZhaiYHuZWuCQianJ 2010 Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42 755 758

7. BudhuAWangXW 2011 Power play: scoring our goals for liver cancer with better GWAS study design. J Hepatol 54 823 824

8. CasperMGrunhageFLammertF 2011 Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark? Hepatology 53 1390 1392

9. LinZHXinYNDongQJWangQJiangXJ 2010 Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis. BMC Gastroenterol 10 145

10. XinYNLinZHJiangXJZhanSHDongQJ 2011 Specific HLA-DQB1 alleles associated with risk for development of hepatocellular carcinoma: a meta-analysis. World J Gastroenterol 17 2248 2254

11. KamataniYWattanapokayakitSOchiHKawaguchiTTakahashiA 2009 A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41 591 595

12. MbarekHOchiHUrabeYKumarVKuboM 2011 A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Human Molecular Genetics 20(19) 3884 3892

13. KumarVKatoNUrabeYTakahashiAMuroyamaR 2011 Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43 455 458

14. MikiDOchiHHayesCNAbeHYoshimaT 2011 Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet 43 797 800

15. GodkinADavenportMHillAV 2005 Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41 1383 1390

16. El-ChennawiFAAufFAMetwallySSMosaadYMEl-WahabMA 2008 HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol Invest 37 661 674

17. YangGLiuJHanSXieHDuR 2007 Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens 69 170 175

18. ZhangSYGuHXLiDYangSFZhongZH 2006 Association of human leukocyte antigen polymorphism with hepatitis B virus infection and genotypes. Jpn J Infect Dis 59 353 357

19. RamezaniAHasanjani RoshanMRKalantarEEslamifarABanifazlM 2008 Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol 23 1716 1721

20. de GrootJSontheimerH 2011 Glutamate and the biology of gliomas. Glia 59 1181 1189

21. SpeyerCLSmithJSBandaMDevriesJAMekaniT 2011 Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat

22. StepulakALukschHUckermannOSifringerMRzeskiW 2011 Glutamate receptors in laryngeal cancer cells. Anticancer Res 31 565 573

23. HernerASauliunaiteDMichalskiCWErkanMDe OliveiraT 2011 Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling. Int J Cancer 129 2349 2359

24. WuCSLuYJLiHPHsuehCLuCY 2010 Glutamate receptor, ionotropic, kainate 2 silencing by DNA hypermethylation possesses tumor suppressor function in gastric cancer. Int J Cancer 126 2542 2552

25. EngLIbrahim-zadaIJarjanaziHSavasSMeschianM 2011 Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines. BMC Med Genomics 4 18

26. PriceALPattersonNJPlengeRMWeinblattMEShadickNA 2006 Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 904 909

27. YangYZhouYLuMAnYLiR 2011 Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Mol Carcinog

28. LiuLXuYLiuZChenJZhangY 2011 IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. Int J Cancer 128 1692 1696

29. PurcellSNealeBTodd-BrownKThomasLFerreiraMA 2007 PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81 559 575

30. BarrettJCFryBMallerJDalyMJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263 265

31. HowieBNDonnellyPMarchiniJ 2009 A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5 e1000529 doi:10.1371/journal.pgen.1000529

32. de BakkerPIMcVeanGSabetiPCMirettiMMGreenT 2006 A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38 1166 1172

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#